VMP 42088111000001100

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Repaglinide 1mg tablets
BNF code 0601023R0AAABAB
Virtual Therapeutic Moiety Repaglinide
Date identifier became valid 21 Jul 2023
Previous product identifier 326048000
Basis of preferred name rINN - Recommended International Non-proprietary
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units tablet
Unit dose unit of measure tablet
Virtual Product Ingredient
Ingredient Repaglinide
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 1.000
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route tablet.oral
Dose Form
Formulation Oral tablet
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Repaglinide 1mg tablets (A A H Pharmaceuticals Ltd)
Repaglinide 1mg tablets (Accord-UK Ltd)
Repaglinide 1mg tablets (Alliance Healthcare (Distribution) Ltd)
Repaglinide 1mg tablets (Medihealth (Northern) Ltd)
Repaglinide 1mg tablets (Rivopharm (UK) Ltd)
Repaglinide 1mg tablets (Viatris UK Healthcare Ltd)
Virtual Medicinal Product Packs
Repaglinide 1mg tablets 30 tablet
Repaglinide 1mg tablets 90 tablet

dm+d data retrieved from TRUD: release NHSBSA_11.2.0_20241118000001, imported on 19th November 2024 at 03:53:26.

Feedback